RACHEL HOLLYWOOD: Open Payments
NPI 1124498415 · OCEAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,469 in 136 payments from 33 companies in 2025. Trend: 2023 $3,410 · 2024 $4,247 · 2025 $2,469
Food & beverage: $2,469
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $660 |
| ABBVIE INC. | 22 | $284 |
| GlaxoSmithKline, LLC. | 13 | $203 |
| Amgen Inc. | 12 | $185 |
| Lilly USA, LLC | 6 | $104 |
| Regeneron Healthcare Solutions, Inc. | 5 | $94 |
| Merck Sharp & Dohme LLC | 5 | $89 |
| Phathom Pharmaceuticals, Inc. | 5 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $65 |
| Kowa Pharmaceuticals America, Inc. | 4 | $61 |
Products named: AIRSUPRA, UBRELVY, DUPIXENT, OTEZLA, FASENRA, BREZTRI, VRAYLAR, TRELEGY ELLIPTA.
Industry payments across NJ — which companies pay providers there.
